Karen A Dawes Repligen Corp (RGEN) insider trading activity

RGEN Quotes by TradingView

Karen A Dawes is of REPLIGEN CORP. Currently has a direct ownership of 91,821 shares of RGEN, which is worth approximately $14 Million. The most recent transaction as insider was on May 11, 2021, when has been sold 285 shares (Common Stock) at a price of $176.85 per share, resulting in proceeds of $50,402. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 91.8K
0.3% 3M change
4.14% 12M change
Total Value Held $14 Million

KAREN A DAWES Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 11 2021
SELL
Open market or private sale
$50,402 $176.85 p/Share
285 Reduced 0.25%
115,449 Common Stock
May 11 2021
BUY
Exercise of conversion of derivative security
$48,300 $3.22 p/Share
15,000 Added 11.47%
115,734 Common Stock

Also insider at

VACC
Vaccitech plc Healthcare
Director
KAD

Karen A Dawes

Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RGEN